- Filed
- Nov 12, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 12, 2024 | 4.95M sh |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $16.68M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $6.11M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $29M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $37.31M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $6.03M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $5.67M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $34.21M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $42.99M |
| Capex | Q3 2024 · Sep 30, 2023 | $355.63K |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | −$5.09M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $2.5M |
| Sga Expense | Q3 2024 · Sep 30, 2023 | $6.93M |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $27.94K |
| Rd Expense | Q3 2024 · Sep 30, 2023 | $67.1K |
| Net Income | Q3 2024 · Sep 30, 2023 | −$3.01M |
| Net Income | Q3 2024 · Sep 30, 2023 | −$1.42M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$3.3M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$1.93M |